NCT06777706View on ClinicalTrials.gov

Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UC

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

September 1, 2024

Study Completion Date

September 1, 2024

Conditions
Ulcerative ColitisInflammatory Bowel Diseases
Interventions
DIETARY_SUPPLEMENT

QD (Qing Dai)

Children age 4 years to 17.9 years with mild to moderate UC will receive QD and dosing will be stratified based on body weight at time of enrollment.

Trial Locations (2)

Unknown

Shaare Zedek Medical Center - The Juliet Keidan Institute of Paediatric Gastroenterology and Nutrition, Jerusalem

Schneider Children's Medical Center, Petah Tikva

All Listed Sponsors
lead

Shaare Zedek Medical Center

OTHER